Fosamax Esophageal Cancer

Unsafe Drugs

In January 2009, a high ranking executive of the Food and Drug Administration wrote in the New England Journal of Medicine that as of May 2008, there have been 23 reports of Fosamax patients developing esophageal tumors. Eight of these patients have since passed away. Additionally, there have been 21 reports of similar cases in Europe and Japan, along with six deaths. Most of these cases showed up at least two years after the patient initially began taking Fosamax.

Similar drugs like Boniva, Actonel, and Didronel have not been linked to esophageal cancer yet. However, these drugs are linked to inflammation of the esophageal tube or esophagitis when not taken as directed. The irritation may be the precursor for cancer.

If you or your wife or mother or other family member has been diagnosed with esophageal cancer and was prescribed Fosamax, you could be eligible for a Fosamax lawsuit. Let's talk.

There are certain risk factors that make some Fosamax patients more likely to develop esophageal tumors. For example, patients with Barrett's esophagus are at a much higher risk. However, more studies need to be done in this area, as other conditions may also put people at risk.

Of course Merck responded defensively saying the risks are minimal as compared to the benefits. Choose your disease - esophageal cancer or osteoporosis? Neither are diseases nobody wants to deal with. Doctors are starting to take sides as the volume of Fosamax lawsuits grow.

Fosamax patient product information: Stop taking FOSAMAX or FOSAMAX PLUS D if you develop new or worsening heartburn, difficult or painful swallowing, or chest pain because these may be signs of serious upper digestive problems, which can include irritation, inflammation, or ulceration of the esophagus.